Posted on August 14, 2009 by Joel Shpigel R.Ph.

New Diabetes Drug ONGLYZA is Now Available

 

A newly approved diabetes drug, Onglyza, is now available in U.S. pharmacies, effective Friday August 14, 2009.

Bristol Myers-Squibb and AstraZeneca PLC, which co-developed and will co-market the drug, said that Onglyza was approved as an adjunct to diet and exercise to improve blood-sugar control in adults for the treatment of type 2 diabetes mellitus.

It belongs to a class of drugs known as DPP-4 inhibitors, and will compete directly with the only other such drug on the market, Merck & Co.'s (MRK) Januvia, which has had the DPP-4 market to itself since it was introduced in 2006.

Click here to learn more about diabetes medications available through Focus Express Mail Pharmacy!

Tags: , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.diabetespharmacist.com/admin/trackback/151055
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.